Obesity and kidney disease: hidden consequences of the epidemic
Journal Title: Clinical Kidney Journal - Year 2017, Vol 10, Issue 1
Abstract
Obesity has become a worldwide epidemic, and its prevalence has been projected to grow by 40% in the next decade. This increasing prevalence has implications for the risk of diabetes, cardiovascular disease and also for chronic kidney disease (CKD). A high body mass index is one of the strongest risk factors for new-onset CKD. In individuals affected by obesity, a compensatory hyperfiltration occurs to meet the heightened metabolic demands of the increased body weight. The increase in intraglomerular pressure can damage the kidneys and raise the risk of developing CKD in the long term. The incidence of obesity-related glomerulopathy has increased 10-fold in recent years. Obesity has also been shown to be a risk factor for nephrolithiasis, and for a number of malignancies including kidney cancer. This year World Kidney Day promotes education on the harmful consequences of obesity and its association with kidney disease, advocating healthy lifestyles and health policy measures that make preventive behaviors an affordable option.
Authors and Affiliations
Csaba P. Kovesdy, Susan L. Furth, Carmine Zoccali, on behalf of the World Kidney Day Steering Committee
Keywords
Related Articles
- EP ID EP679671
- DOI 10.1093/ckj/sfw139
- Views 66
- Downloads 0
Circulating miRNAs as biomarkers of kidney disease
Interest in microRNAs (miRNAs) has dramatically increased in recent years not only because they regulate mRNA expression, and thus many physiological or pathophysiological processes, but also because they could serve as...
Quantification of bleeding volume using computed tomography and clinical complications after percutaneous renal biopsy
Normally distributed data are presented as the mean ± standard deviation (SD), with nonparametric data presented as the median and 25th–75th percentile. Statistical analyses were performed...
Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods
Kidney transplantation (KTx) represents the best available treatment for patients with end-stage renal disease. Still, full benefits of KTx are undermined by acute rejection (AR). The diagnosis of AR ultimately relies on...
The efficacy of rituximab in adult frequently relapsing minimal change disease
Corticosteroids are the basis of treatment for nephrotic syndrome due to minimal change disease (MCD), but 25% of patients have frequently relapsing nephrotic syndrome (FRNS) and 30% become steroid dependent. Prolonged u...
Impact of poverty and race on pre-end-stage renal disease care among dialysis patients in the United States
Access to nephrology care prior to end-stage renal disease (ESRD) is significantly associated with lower rates of morbidity and mortality. We assessed the association of area-level and individual-level indicators of pove...